Case raises fresh questions about AI regulation, digital health safeguards and whether chatbots are drifting into unlicensed clinical territory.
Case raises fresh questions about AI regulation, digital health safeguards and whether chatbots are drifting into unlicensed clinical territory.
This content is for paid subscribers only.
Start your free trial nowor purchase a monthly or annual subscription to read.